Clinical Trial Update: French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin

View source ↗

Summary

This clinical trial update discusses outcomes and resistance in a French cohort of chronic hepatitis C patients treated with protease inhibitors (telaprevir or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)
• Pegylated Interferon Alfa-2b (pegylated interferon alfa-2b)
• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Chronic Hepatitis C | Status: COMPLETED